July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
NEW FORMULATIONS BASED ON INNOVATIVE BRILLIANT BLUE G DERIVATIVE TO STAIN RETINAL MEMBRANES
Author Affiliations & Notes
  • Claudio Bucolo
    Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
    Center for Research in Ocular Pharmacology-CERFO, University of Catania, Catania, Italy
  • Filippo Drago
    Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
    Center for Research in Ocular Pharmacology-CERFO, University of Catania, Catania, Italy
  • Mario R Romano
    Biomedical Sciences, Humanitas University, Milano, Italy
  • Marco Rao
    Drug Sciences, University of Catania, Catania, Italy
  • Angelo Spadaro
    Drug Sciences, University of Catania, Catania, Italy
  • Footnotes
    Commercial Relationships   Claudio Bucolo, None; Filippo Drago, None; Mario Romano, None; Marco Rao, None; Angelo Spadaro, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 39. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Claudio Bucolo, Filippo Drago, Mario R Romano, Marco Rao, Angelo Spadaro; NEW FORMULATIONS BASED ON INNOVATIVE BRILLIANT BLUE G DERIVATIVE TO STAIN RETINAL MEMBRANES. Invest. Ophthalmol. Vis. Sci. 2019;60(9):39. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the ability of new formulations based on an innovative synthetic brilliant blue G derivative (PBB) to stain internal limiting membrane (ILM) in order to improve vitreoretinal surgery.

Methods : New PBBformulations were evaluated in enucleated porcine eyes in comparison with commercial formulations based on Brilliant Blue G (BBG) and its derivative methyl-BBG. Forty microliters of each formulation were slowly injected over the retinal surface. After 30 seconds, formulation was removed and the retinal surface was rinsed out with BSS. The peeling of ILM was carried out by forceps and the retina (RET) underneath the area of ILM peeling was also collected. The amount of the dye molecules (BBG, methyl-BBG and PBB) in ILM and RET was detected by HPLC–DAD analysis. Statistical analysis was performed using ANOVA followed by the Bonferroni-Dunn post hoc.

Results : Among the formulations tested, PBBwas the dye present with the highest concentration in ILM and with the lowest concentration in RET. PBBlevels in ILM were significantly (p<0.01) higher compared to BBG and methyl BBG groups, with an increase of dye amount of 2.9- and 6.0-fold, respectively. BBG and methyl-BBG concentrations in RET were significantly (p<0.01) higher (20- and 11-fold increase in the BBG and methyl-BBG groups, respectively).

Conclusions : The high selective staining of the ILM achieved by the new synthetic PBB™ formulations may improve the surgical techniques enhancing the discrimination of retinal membranes on one hand and reducing the amount of dye that reaches the inner retina on the other, lowering the risk of iatrogenic retinal damage.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×